Kintara Therapeutics Publicizes Fiscal 2022 Monetary Outcomes and Supplies Company Replace September 27, 2022 admin Financial E-learning SAN DIEGO, Sept. 27, 2022 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Firm”), a biopharmaceutical firm targeted on the event of recent strong tumor most... Continue Reading